CLINICAL SIGNIFICANCE OF PROGRAMMED DEATH-1 LIGAND-1 EXPRESSION IN PATIENTS WITH NON-SMALL CELL LUNG CANCER: A 5-YEAR-FOLLOW-UP STUDY

被引：0
|
作者：
Chen, Y-B [1 ]
Mu, C-Y [1 ]
Huang, J-A [1 ]
机构：
[1] Soochow Univ, Affiliated Hosp 1, Dept Resp Med, Suzhou, Peoples R China
来源：
RESPIROLOGY | 2011年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：163 / 163
页数：1
相关论文
共 50 条
  • [31] A Comparison of Five Different Immunohistochemistry Assays for Programmed Death Ligand-1 Expression in Non-Small Cell Lung Cancer Samples
    Soo, Ross
    Lim, Joey
    Asuncion, Bernadette Reyna
    Fazreen, Zul
    Herrera, Maria
    Omar, Feroz
    Seet, Ju Ee
    Bryne, David
    Hendry, Shona
    Fox, Stephen
    Soong, Richie
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S801 - S801
  • [32] Expression of programmed death ligand-1 on tumor cells varies pre and post chemotherapy in non-small cell lung cancer
    Jin Sheng
    Wenfeng Fang
    Juan Yu
    Nan Chen
    Jianhua Zhan
    Yuxiang Ma
    Yunpeng Yang
    Yan Huang
    Hongyun Zhao
    Li Zhang
    Scientific Reports, 6
  • [33] Expression of programmed death ligand-1 on tumor cells varies pre and post chemotherapy in non-small cell lung cancer
    Sheng, Jin
    Fang, Wenfeng
    Yu, Juan
    Chen, Nan
    Zhan, Jianhua
    Ma, Yuxiang
    Yang, Yunpeng
    Yanhuang
    Zhao, Hongyun
    Zhang, Li
    SCIENTIFIC REPORTS, 2016, 6
  • [34] Programmed death ligand-1 expression in non-small cell lung cancer in a Western Australian population and correlation with clinicopathologic features
    Ye, Linda
    Leslie, Connull
    Jacques, Angela
    Ardakani, Nima Mesbah
    Amanuel, Benhur
    Millward, Michael
    MODERN PATHOLOGY, 2019, 32 (04) : 524 - 531
  • [35] Programmed Death-Ligand-1 Expression in Non-Small Cell Lung Cancer and Prognosis
    Sahin, Songul
    Batur, Sebnem
    Aydin, Ovgu
    Ozturk, Tulin
    Turna, Akif
    Oz, Buge
    BALKAN MEDICAL JOURNAL, 2019, 36 (03) : 184 - 189
  • [36] Has programmed cell death ligand-1 MET an accomplice in non-small cell lung cancer?-a narrative review
    Dempke, Wolfram C. M.
    Fenchel, Klaus
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (06) : 2667 - 2682
  • [37] MicroRNAs aid the assessment of programmed death ligand 1 expression in patients with non-small cell lung cancer
    Grenda, Anna
    Nicos, Marcin
    Szczyrek, Michal
    Krawczyk, Pawel
    Kucharczyk, Tomasz
    Jarosz, Bozena
    Pankowski, Juliusz
    Sawicki, Marek
    Szumilo, Justyna
    Bukala, Paulina
    Milanowski, Janusz
    ONCOLOGY LETTERS, 2019, 17 (06) : 5193 - 5200
  • [38] Recent advances of immunotherapy in lung cancer: anti-programmed cell death-1/programmed death ligand-1 antibodies
    Yang, Lu-Lu
    Wu, Yi-Long
    LUNG CANCER MANAGEMENT, 2014, 3 (02) : 175 - 190
  • [39] Temporal evolution of programmed death-ligand 1 expression in patients with non-small cell lung cancer
    Nam, Chang Hyun
    Koh, Jaemoon
    Ock, Chan-Young
    Kim, Miso
    Keam, Bhumsuk
    Kim, Tae Min
    Jeon, Yoon Kyung
    Kim, Dong-Wan
    Chung, Doo Hyun
    Heo, Dae Seog
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2021, 36 (04): : 975 - +
  • [40] Programmed Cell Death-1 and Programmed Cell Death Ligand-1 in Childhood Acute B-Lymphoblastic Leukemia: Expression and Significance as Biomarker
    Allam, Ahmed Ahmed
    Ahmed, Heba A.
    Hassan, Mohammad Ahmad
    Khaled, Safaa A. A.
    Shibl, Azza
    Osman, Amira Mahmoud
    Ali, Nada Mohamed Rafat
    Ahmed, Nesma Mokhtar
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2025,
12345